Prognostic significance of silent coronary artery disease in type 2 diabetes

Herz

Volumn 31, Issue 3, 2006, Pages 240-245

  Zellweger, Michael J ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Coronary artery disease; Diabetes mellitus; Myocardial perfusion SPECT; Prognosis; Silent ischemia

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; DIABETIC PATIENT; DIAGNOSTIC TEST; DISEASE COURSE; EPIDEMIOLOGICAL DATA; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HIGH RISK PATIENT; HUMAN; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PROGNOSIS; REVASCULARIZATION; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY;

CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; COMORBIDITY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HUMANS; MYOCARDIAL ISCHEMIA; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 33745120185     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-006-2790-1     Document Type: Article

References (39)

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-7.
2. Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34.
3. Goraya TY, Leibson CL, Palumbo PJ, et al. Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study. J Am Coll Cardiol 2002;40:946-53.
4. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979;241:2035-8.
5. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovasculardisease:a statement for healthcare professionals from the American Heart Association. Circulation 1999;100:1134-46.
6. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham study. Circulation 1979;59:8-13.
7. Langer A, Freeman MR, Josse RG, et al. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sym pathetic denervation and its relation to autonomie dysfunction and silent myocardial ischemia. J Am Coll Cardiol 1995;25:610-8.
8. Ambepityia G, Kopelman PG, Ingram D, et al. Exertional myocardial ischemia in diabetes: a quantitative analysis of anginal perceptual threshold and the influence of autonomie function. J Am Coll Cardiol 1990;15:72-7.
9. Hikita H, Kurita A, Takase B, et al. Usefulness of plasma beta-endorphin level, pain threshold and autonomicfunction in assessing silent myocardial ischemia in patients with and without diabetes mellitus. Am J Cardiol 1993;72:140-3.
10. Rosen SD, Paulesu E, Nihoyannopoulos P, et al. Silent schemia as a central problem: regional brain activation compared in silent and painful myocardial ischemia. Ann Intern Med 1996;124:939-49.
11. Zellweger MJ, Pfisterer ME. Silent coronary artery disease in patients with diabetes mellitus. Swiss Med Wkly 2001;131:427-32.
12. Langer A, Freeman MR, Josse RG, et al. Detection of silent myocardial ischemia in diabetes mellitus. Am J Cardiol 1991;67:1073-8.
13. Koistinen MJ. Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. BMJ 1990;301:92-5.
14. Fleg JL. Prevalence and prognostic significance of exercise-induced silent myocardial ischemia in apparently healthy subjects. Am J Cardiol 1992;69:14B-8B.
15. MiSAD. Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group. Am J Cardiol 1997;79:134-9.
16. Wackers FJ, Young LH, Inzucchi SE, et al. Detection of silent myocardial Ischemia in Asymptomatic Diabetic subjects: The DIAD study. Diabetes Care 2004;27:1954-61.
17. Nesto RW, Watson FS, Kowalchuk GJ, et al. Silent myocardial ischemia and infarction in diabetics with peripheral vascular disease: assessment bydipyridamolethallium-201 scintigraphy. Am Heart J 1990;120:1073-7.
18. Rutter MK, McComb JM, Brady S, et al. Silent myocardial ischemia and microalbuminuria in asymptomatic subjects with non-insulin-dependent diabetes mellitus. Am J Cardiol 1999;83:27-31.
19. Vinik AI, Maser RE, Mitchell BD, et al. Diabetic autonomic neuropathy. Diabetes Care 2003;26:1553-79.
20. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979;2:120-6.
21. Donnan PT, Boyle DI, Broomhall J, et al. Prognosis following first acute myocardial infarction in type 2 diabetes: a comparative population study. Diabet Med 2002;19:448-55.
22. Weiner DA, Ryan TJ, Parsons L, et al. Significance of silent myocardial ischemia during exercise testing in patients with diabetes mellitus: a report from the Coronary Artery Surgery Study (CASS) Registry. Am J Cardiol 1991;168:729-34.
23. Pancholy SB, Schalet B, Kuhlmeier V, et al. Prognostic significance of silent ischemia. J Nucl Cardiol 1994;1:434-40.
24. Rajagopalan N, Miller TD, Hodge DO, et al. Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J Am Coll Cardiol 2005;45:43-9.
25. Rajagopalan N, Miller TD, Hodge DO, et al. Identifying high risk asymptomatic diabetics who are candidates for screening stress SPECT. J Am Coll Cardiol 2002;39:382A.
26. Zellweger MJ, Hachamovitch R, Kang X, et al. Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. Eur Heart J 2004;25:543-50.
27. Giri S, Shaw LJ, Murthy DR, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002;105:32-40.
28. Kang X, Berman DS, Lewin H, et al. Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus. Am Heart J 1999;137:949-57.
29. Kang X, Berman DS, Lewin HC,et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J 1999;138:1025-32.
30. Hachamovitch R, Hayes S, Friedman JD, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what isthe warranty period of a normal scan? J Am Coll Cardiol 2003;41:1329-40.
31. Schurgin S, Rich S, Mazzone T. Increased prevalence of significant coronary artery calcification in patients with diabetes. Diabetes Care 2001;24:335-8.
32. Raggi P, Shaw LJ, Berman DS, et al. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol 2004;43:1663-9.
33. Vinik AI, Mehrabyan A. Diagnosis and management of diabetic autonomic neuropathy. Compr Ther 2003;29:130-45.
34. Maser RE, Mitchell BD, Vinik AI, et al. The association between cardiovascularautonomic neu ropathyand mortality in individuals with diabetes:a meta-analysis. Diabetes Care 2003;26:1895-901.
35. ADA. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida. American Diabetes Association. Diabetes Care 1998;21:1551-9.
36. Wackers FJ, Zaret BL. Detection of myocardial ischemia in patients with diabetes mellitus. Circulation 2002;105:5-7.
37. Davies RF, Goldberg AD, Forman S, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 1997;95: 2037-43.
38. Sorajja P, Chareonthaitawee P, Rajagopalan N, et al. Improved survival in asymptomatic diabetic patients with high-risk SPECT imaging treated with coronary artery bypass grafting.Circulation 2005;112:1311-6.
39. Callister TO, Raggi P, Cooil B, et al. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 1998;339:1972-8.